| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
| Bavituximab |
➤ Sign Up |
Multispecific constructs |
AbbVie Stemcentrx LLC (North Chicago, IL) |
➤ Sign Up |
| Bavituximab |
➤ Sign Up |
.beta.-glucan methods and compositions that affect the tumor microenvironment |
BIOTHERA, INC. (Eagan, MN) |
➤ Sign Up |
| Bavituximab |
➤ Sign Up |
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein |
CureVac AG (Tubingen, DE) |
➤ Sign Up |
| Bavituximab |
➤ Sign Up |
Method of treating pancreatic cancer |
ChemoCentryx, Inc. (Mountain View, CA) |
➤ Sign Up |
| Bavituximab |
➤ Sign Up |
Modulators of toll-like receptor 7 |
Gilead Sciences, Inc. (Foster City, CA) |
➤ Sign Up |
| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
